Novartis's Cancer-Drug Patent Denied by India's Supreme Court

India's Supreme Court denied Novartis AG's request for patent protection for its Gleevec cancer treatment, allowing the nation's generic-drug makers to continue to sell copies of the drug at a lower price.

http://washpost.bloomberg.com/Story?docId=1376-MKBM0C6KLVRB01-2Q0U2EKICPDU6RR6ICEPQRNHMS